Browse / Cagrilintide
Long-acting amylin analogue
Cagrilintide is a long-acting amylin analogue developed for metabolic research and clinical programs, often discussed alongside GLP-1 agonists. It is not a licensed monotherapy in most markets. All catalog material is for laboratory research use only.
Amylin receptor agonist, Satiety and gastric-emptying models, Combination literature with incretins
Amylin receptors in the area postrema and hypothalamus contribute to satiety and gastric-emptying control. Acylated analogues extend half-life versus native amylin.
Long-acting amylin analog (acylated); primary structure on certificate.
Development PK, not a protocol.
Age verification
The products on this website are only for research professionals of 21+ years of age, purchasing for research purposes only. Any human or animal consumption is strictly prohibited.
Research Use Only — not for human or animal consumption.
You must be at least 21 years old to enter this website. Please leave and return when you meet the age requirement.